Acasti Pharma reported $1.61M in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Acasti Pharma USD 1.61M 364K Sep/2026
Addus HomeCare USD 171.44M 3.3M Sep/2026
Amarin USD 175.14M 10.94M Sep/2026
Cassava Sciences USD 41.95M 1.79M Sep/2026
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Option Care Health USD 850.53M 31.05M Sep/2026
Organigram Holdings CAD 107.28M 18.54M Jun/2026
Tilray USD 259.32M 8.32M Sep/2025